The migration tool rewrites complex routines into PostgreSQL cursors, but application teams must also change testing and data access for cursor-based outputs.

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

When a wound does not heal properly, it leaves a scar. Similarly, mutations—which are permanent changes to genetic code—are ...

AI-native drug discovery advances neuroscience target with Roche while cutting cash guidance.

We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.

Microsoft Threat Intelligence examines DeadLock ransomware, an emerging financially motivated operation distinguished by its ...

Brianna Tobritzhofer is a nationally credentialed Registered Dietitian and experienced health writer with over a decade of leadership in nutrition program development, policy compliance, and public ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...